Volition Presents New Liquid Biopsy Method for Early-Stage Cancer
VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.
Read MorePosted by Andy Lundin | Oct 23, 2023 | Cancer, Molecular Diagnostics |
VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.
Read MorePosted by Andy Lundin | Oct 23, 2023 | Lung Cancer, Molecular Diagnostics |
NeXT Personal ctDNA assay shown to be more sensitive and predictive of clinical outcomes in early-stage lung cancer patients
Read MorePosted by Andy Lundin | Oct 19, 2023 | Lung Cancer |
Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients.
Read MorePosted by Chris Wolski | Oct 11, 2023 | Molecular Diagnostics |
For Strata Oncology, clinical diagnostics is critical for the move to a precision medicine model. It’s doing so with its Strata Select test.
Read MorePosted by Andy Lundin | Oct 10, 2023 | Cancer |
The genomic profiling test is approved to identify patients with solid tumors with RET gene fusions who may benefit from Retevmo treatment.
Read More